Vertex Pharmaceuticals Incorporated

$VRTX - Nasdaq - Pharmaceuticals and Biotechnology
0 LAST
0 CHANGE $
0 CHANGE %
loader
ON 3
WATCHLISTS

COMMUNIQUÉ DETAILS

Up 0 0 Down
Vertex To Announce Second Quarter 2013 Financial Results On July 29

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2013 financial results on Monday, July 29, 2013 after the financial markets close. The company will host a conference call and webcast at 5:00 p.m. ET.

The conference call will be webcast live and a link to the webcast may be accessed from the “Vertex Events” page of Vertex’s website at www.vrtx.com. A replay of the conference call and webcast will be archived on the company’s website until August 5, 2013. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.

Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis and other life-threatening diseases.

Founded more than 20 years ago in Cambridge, Mass., we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and for three years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. Vertex’s press releases are available at www.vrtx.com.

VRTX-WEB

Vertex (Investors):
Michael Partridge, 617-341-6108
or
Kelly Lewis, 617-961-7530
or
Vertex (Media):
Zach Barber, 617-341-6470
mediainfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

SHARE THIS: Twitter StockTwits LinkedIn Google Plus SHORT URL: http://bdvt.co/Kls

SIGN IN TO BOARDVOTE

FORGOT PASSWORD?